Pharmacologically preventing Fis1 binding to its partner, dynamin-related protein 1 (Drp1), prevented mitochondrial impairment, microglial activation, and LD formation, which attenuated cognitive impairment and neurodegeneration. Here, DNM1L is linked to Cognitive impairment.